Tehraoui: Market Surveillance, Local Production, and Digitalization to Secure Drug Supply Chains
In response to the risks of shortages and the ongoing tensions affecting global supply chains, Morocco is strengthening its pharmaceutical security framework. Updating the list of essential medicines, increasing market surveillance, modernizing procedures, and developing local production are among the key measures being implemented to ensure the availability of treatments and enhance the resilience of the sector.
An Updated List of Essential Medicines
The revision of the national list of essential medicines is a cornerstone of this strategy. This tool allows for the identification of the system’s priority health needs and focuses procurement efforts on the most critical treatments for patient care.
This update also aims to adapt national priorities to evolving health needs and to optimize the management of available resources.
A Monitoring System to Anticipate Tensions
Authorities are also relying on a strengthened monitoring system designed to detect potential disruptions before they impact the market.
Based on continuous stock monitoring and coordination among various stakeholders in the pharmaceutical chain, this mechanism is expected to enable quicker interventions in the event of shortages for specific medications and ensure better continuity of supply.
Digitalization as a Performance Lever
The modernization of the sector also involves accelerating the digital transformation of regulatory procedures.
Digitizing the processes of drug registration and authorization is expected to reduce administrative delays, improve transparency, and enhance the overall efficiency of the system, while facilitating the work of industry operators.
Strengthening National Production
Beyond stock management, the strategy emphasizes developing national industrial capabilities. The goal is to bolster local medicine manufacturing, promote the use of generics, and attract new investments in high-value pharmaceutical activities.
This direction is in line with a global trend of industrial relocation and securing supply chains in strategic sectors.
Why is International Expertise Essential?
However, the consolidation of pharmaceutical sovereignty does not solely depend on national capabilities. It also relies on the ecosystem of international pharmaceutical companies established in Morocco, whose contributions remain a significant asset for the sector.
Thanks to their industrial expertise, research and development capabilities, and integration into global innovation networks, these players contribute to technology transfer, enhance human resources’ skills, and introduce next-generation therapeutic solutions.
The Covid-19 pandemic highlighted the crucial role these groups play in maintaining the continuity of health product supply and in rapidly accessing medical innovations. As the Kingdom aims to strengthen its strategic autonomy, the challenge lies in combining the growth of local production with leveraging international expertise to build a more competitive, innovative, and resilient pharmaceutical industry.
